Dual mode 18F-labelled theranostic compounds and uses thereof
US12427209B2 · kind B2 · utility
0Cited by
11References
5Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 18, 2019 |
| Grant date | Sep 30, 2025 |
| Priority date | — |
| Expiry date | Dec 14, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F5/027
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound or molecular complex. The compound or molecular complex comprises: a metal chelator configured for chelation with a radioactive isotope or a non-radioactive isotope; and a trifluoroborate (BF3)-containing moiety configured for 19F/18F exchange or a precursor thereof; and optionally a cell-targeting domain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.